| 5 mins | 30 mins | Hourly | Daily | Weekly |
|---|---|---|---|---|
| SELL | SELL | SELL | SELL | SELL |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MA5 | 1.15▼ | 1.19▼ | 1.19▼ | 1.29▼ | 1.28▼ |
| MA10 | 1.24▼ | 1.26▼ | 1.26▼ | 1.29▼ | 1.31▼ |
| MA20 | 1.28▼ | 1.29▼ | 1.29▼ | 1.31▼ | 1.37▼ |
| MA50 | 1.47▼ | 1.50▼ | 1.53▼ | 1.41▼ | N/A |
| MA100 | 1.76▼ | 1.57▼ | 1.50▼ | 1.67▼ | N/A |
| MA200 | 1.71▼ | 1.64▼ | 1.67▼ | N/A | N/A |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MACD | -0.017▼ | -0.016▼ | -0.018▼ | N/A | N/A |
| RSI | 30.004▼ | 32.530▼ | 33.927▼ | N/A | N/A |
| STOCH | 24.420 | 36.700 | 36.700 | 66.184 | 7.354▼ |
| WILL %R | -100.000▼ | -100.000▼ | -100.000▼ | -100.000▼ | -100.000▼ |
| CCI | -139.469▼ | -178.594▼ | -178.594▼ | -335.394▼ | -149.686▼ |
| MA | $ACHV Price Crossed Below MA(26) | Set Alert |
| MA | $ACHV Price Crossed Below MA(13) | Set Alert |
| MA | $ACHV Price Crossed Below MA(7) | Set Alert |
| ▼ GAP | $ACHV Open Gap Down %5 | Set Alert |
| ▼ GAP | $ACHV Open Gap Down %3 | Set Alert |
| ▼ GAP | $ACHV Open Gap Down %2 | Set Alert |
| ▼ BREAK | $ACHV Price Breaks 60 Days Low | Set Alert |
| ▼ BREAK | $ACHV Price Breaks 30 Days Low | Set Alert |
| ▼ BREAK | $ACHV Price Breaks 20 Days Low | Set Alert |
| ▼ BREAK | $ACHV Price Breaks 10 Days Low | Set Alert |
|
Thursday, May 17, 2018 06:17 AM
SEATTLE - Achieve Life Sciences, Inc. (NASDAQ: ACHV), a clinical-stage pharmaceutical company committed to the global development and commercialization of cytisine for smoking cessation, today announced first quarter 2018 financial results and recent ...
|
|
Friday, May 11, 2018 05:30 AM
Achieve Life Sciences (NASDAQ:ACHV) slips 4% premarket on light volume. Yesterday after the close it filed a preliminary prospectus for an $8M public offering of Units. Now read: Stellar Bio prices equity offering; shares down 38% premarket »
|
|
Wednesday, May 09, 2018 10:15 PM
"Clinical study results continue to reinforce the established benefit of cytisine as a potential new treatment option for smoking cessation in the U.S.," commented Rick Stewart, Chairman and Chief Executive Officer of Achieve Life Sciences. "The upcoming ...
|
| date | open | high | low | close | volume |
|---|---|---|---|---|---|
| 11/05/18 | 1.095 | 1.10 | 1.045 | 1.045 | 264,550 |
| 26/04/18 | 1.41 | 1.41 | 1.41 | 1.41 | 3,560 |
| 25/04/18 | 1.31 | 1.31 | 1.31 | 1.31 | 6,083 |
| 24/04/18 | 1.34 | 1.34 | 1.34 | 1.34 | 4,137 |
| 19/04/18 | 1.365 | 1.365 | 1.365 | 1.365 | 31,348 |
| 12/04/18 | 1.34 | 1.34 | 1.31 | 1.31 | 57,061 |
| 11/04/18 | 1.27 | 1.29 | 1.27 | 1.29 | 15,060 |
| 10/04/18 | 1.28 | 1.28 | 1.28 | 1.28 | 20,367 |
| 09/04/18 | 1.29 | 1.29 | 1.29 | 1.29 | 36,538 |
| 04/04/18 | 1.27 | 1.2932 | 1.2601 | 1.28 | 21,706 |
|
|
||||
|
|
||||
|
|
||||
|
|